Press Releases

Covetrus will release fourth quarter and full year 2019 results after the market close on Tuesday, March 3, 2020.

Covetrus Script Assist is a convenient way for veterinarians to leverage practice management system information to more proactively prescribe preventative medications for patients with past or upcoming appointments.

Covetrus announced that it has entered into a definitive agreement to sell its scil animal care business (“scil”) to Heska Corporation (“Heska”) (NASDAQ: HSKA) for a purchase price of $125 million in cash, subject to customary closing adjustments.

We at Covetrus are deeply saddened by the severe impact and loss of life resulting from the widespread bushfires gripping Australia. Thankfully, our Australian colleagues are safe.

Industry veterans Mike Ellis and David Hinton promoted to executive vice president, will take on additional global responsibilities for Covetrus; Georgia Wraight promoted to executive vice president.

Covetrus™ announced that the Company will be participating in the J.P. Morgan 38th Annual Healthcare Conference in San Francisco, CA.

Stuart Gleichenhaus to serve as interim Chief Financial Officer, search for permanent replacement currently underway; Dustin Finer appointed as Chief Administrative Officer.

Covetrus Announces Financial Results for Third Quarter of 2019

In recognition of National Diabetes Month, Covetrus®  will donate $1 to The Pet Fund® for every order that includes a featured diabetes care product throughout November.

Board chair Wolin to assume role as acting CEO and president, lead independent director Laskawy to serve as board chair.